Quince Therapeutics Inc (QNCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -56,828 | -31,385 | -51,660 | -89,945 | -76,849 |
| Depreciation Amortization | 14,968 | 4,203 | 916 | 1,222 | 967 |
| Income taxes - deferred | N/A | -248 | -284 | N/A | N/A |
| Accounts payable and accrued liabilities | 927 | -288 | -5,943 | 1,356 | 480 |
| Other Working Capital | -484 | 1,977 | -9,829 | -4,261 | 10,227 |
| Other Operating Activity | 9,513 | 7,449 | 22,762 | 28,696 | 14,357 |
| Operating Cash Flow | $-31,904 | $-18,292 | $-44,038 | $-62,932 | $-50,818 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 82,493 | N/A | -52,379 |
| PPE Investments | -257 | -70 | -63 | -180 | -52 |
| Net Acquisitions | N/A | -2,116 | 10,593 | N/A | N/A |
| Purchase Of Investment | -89,562 | -113,781 | -75,021 | -38,789 | N/A |
| Sale Of Investment | 111,727 | 111,209 | N/A | 97,921 | N/A |
| Other Investing Activity | 0 | -1,000 | 0 | 0 | 0 |
| Investing Cash Flow | $21,908 | $-5,758 | $18,002 | $58,952 | $-52,431 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -6 | -49 | N/A | -34 |
| Common Stock Issued | 225 | 149 | 756 | 6,808 | 1,282 |
| Other Financing Activity | -5,000 | 0 | 0 | 0 | 117,628 |
| Financing Cash Flow | $-4,775 | $143 | $707 | $6,808 | $118,876 |
| Exchange Rate Effect | 231 | 80 | 184 | 55 | N/A |
| Beginning Cash Position | 20,752 | 44,579 | 69,724 | 66,841 | 51,214 |
| End Cash Position | 6,212 | 20,752 | 44,579 | 69,724 | 66,841 |
| Net Cash Flow | $-14,540 | $-23,827 | $-25,145 | $2,883 | $15,627 |
| Free Cash Flow | |||||
| Operating Cash Flow | -31,904 | -18,292 | -44,038 | -62,932 | -50,818 |
| Capital Expenditure | -257 | -160 | -133 | -180 | -52 |
| Free Cash Flow | -32,161 | -18,452 | -44,171 | -63,112 | -50,870 |